These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26884304)
1. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach. Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304 [TBL] [Abstract][Full Text] [Related]
2. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies. Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981 [TBL] [Abstract][Full Text] [Related]
3. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin. Roszczyk M; Juszczak M Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736 [TBL] [Abstract][Full Text] [Related]
4. Oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system is stimulated by triptorelin. Juszczak M; Roszczyk M Endokrynol Pol; 2012; 63(3):176-81. PubMed ID: 22744622 [TBL] [Abstract][Full Text] [Related]
5. Hypothalamic gonadotropin-releasing hormone receptor activation stimulates oxytocin release from the rat hypothalamo-neurohypophysial system while melatonin inhibits this process. Juszczak M; Boczek-Leszczyk E Brain Res Bull; 2010 Jan; 81(1):185-90. PubMed ID: 19874874 [TBL] [Abstract][Full Text] [Related]
6. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system. Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234 [TBL] [Abstract][Full Text] [Related]
7. Role of tachykinin receptors and melatonin in oxitocin secretion from isolated rat hypothalmo-neurohypophysial system. Juszczak M; Furykiewicz-Nykiś K; Stempniak B J Physiol Pharmacol; 2004 Dec; 55(4):739-49. PubMed ID: 15613740 [TBL] [Abstract][Full Text] [Related]
8. Melatonin MT López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968 [TBL] [Abstract][Full Text] [Related]
9. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258 [TBL] [Abstract][Full Text] [Related]
10. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors. Wodowska J; Ciosek J Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889 [TBL] [Abstract][Full Text] [Related]
11. New evidence of melatonin receptor contribution to ram sperm functionality. Gonzalez-Arto M; Luna C; Pérez-Pé R; Muiño-Blanco T; Cebrián-Pérez JA; Casao A Reprod Fertil Dev; 2016 Jun; 28(7):924-935. PubMed ID: 25515626 [TBL] [Abstract][Full Text] [Related]
12. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. Sumaya IC; Masana MI; Dubocovich ML J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095 [TBL] [Abstract][Full Text] [Related]
13. Melatonin influences somatostatin secretion from human pancreatic δ-cells via MT1 and MT2 receptors. Zibolka J; Mühlbauer E; Peschke E J Pineal Res; 2015 Mar; 58(2):198-209. PubMed ID: 25585597 [TBL] [Abstract][Full Text] [Related]
14. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies. Juszczak M J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of gonadotrophin-releasing hormone (GnRH), its analogues and melatonin. Boczek-Leszczyk E; Stempniak B; Juszczak M J Physiol Pharmacol; 2010 Aug; 61(4):459-66. PubMed ID: 20814074 [TBL] [Abstract][Full Text] [Related]
16. Melatonin stimulates the secretion of progesterone along with the expression of cholesterol side-chain cleavage enzyme (P450scc) and steroidogenic acute regulatory protein (StAR) in corpus luteum of pregnant sows. Zhang W; Wang Z; Zhang L; Zhang Z; Chen J; Chen W; Tong D Theriogenology; 2018 Mar; 108():297-305. PubMed ID: 29277070 [TBL] [Abstract][Full Text] [Related]
17. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Juszczak M; Stempniak B Brain Res Bull; 2003 Jan; 59(5):393-7. PubMed ID: 12507691 [TBL] [Abstract][Full Text] [Related]
18. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277 [TBL] [Abstract][Full Text] [Related]
19. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors]. Schuster C J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828 [TBL] [Abstract][Full Text] [Related]
20. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Fink T; Glas M; Wolf A; Kleber A; Reus E; Wolff M; Kiefer D; Wolf B; Rensing H; Volk T; Mathes AM Crit Care Med; 2014 Jan; 42(1):e22-31. PubMed ID: 24145838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]